FDA Trials for Oral Insulin

1401

By: Sharon Kellaher

The FDA has given the go-ahead for human clinical trials of the oral insulin formulation made by Generex Biotechnology. Called Oralgen in the United States, the liquid insulin is taken with Generex’s aerosol applicator.

Yet news from other clinical trials may be hard for people with diabetes to swallow. Generex says Oralgen “fell somewhere between” a placebo and injected insulin” when tested in other countries.

After analyzing the results of all trials performed so far, Bernard Zinman, MD, University of Toronto professor and director of the Banting and Best Diabetes Center, will develop Generex’s research plan for FDA approval.

Comments

comments

Diabetes Health Medical Disclaimer
The information on this site is not intended or implied to be a substitute for professional medical advice, diagnosis or treatment. All content, including text, graphics, images, and information, contained on or available through this website is for general information purposes only. Opinions expressed here are the opinions of writers, contributors, and commentators, and are not necessarily those of Diabetes Health. Never disregard professional medical advice or delay seeking medical treatment because of something you have read on or accessed through this website.